Title:
COMPOUND AS GLP-1 RECEPTOR AGONIST AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/066356
Kind Code:
A1
Abstract:
Provided in the present application are a compound as represented by formula (I) and the use thereof.
The compound as represented by formula (I) provided in the present application can be used as an effective glucagon-like peptide-1 (GLP-1) receptor agonist, has excellent GLP-1R receptor agonistic activity and a significant effect of reducing blood glucose, has good pharmacokinetic characteristics, and provides more choices for the prevention and/or treatment of diseases, conditions or disorders related to GLP-1 activity, thereby having good clinical application prospects.
Inventors:
WANG TONG (CN)
HAO YAN (CN)
TANG MULIN (CN)
DING JUPING (CN)
YU QIANG (CN)
CHEN BIN (CN)
OUYANG ZHENWU (CN)
HAO YAN (CN)
TANG MULIN (CN)
DING JUPING (CN)
YU QIANG (CN)
CHEN BIN (CN)
OUYANG ZHENWU (CN)
Application Number:
PCT/CN2022/126581
Publication Date:
April 27, 2023
Filing Date:
October 21, 2022
Export Citation:
Assignee:
CGENETECH SUZHOU CHINA CO LTD (CN)
International Classes:
C07D405/14; A61K31/4427; A61K31/497; A61P3/10; A61P9/00; C07D401/14; C07D487/04
Domestic Patent References:
| WO2022192430A1 | 2022-09-15 | |||
| WO2022109182A1 | 2022-05-27 | |||
| WO2022111624A1 | 2022-06-02 | |||
| WO2021018023A1 | 2021-02-04 |
Foreign References:
| CN113773310A | 2021-12-10 | |||
| CN113227068A | 2021-08-06 | |||
| CN112566637A | 2021-03-26 | |||
| CN110325530A | 2019-10-11 |
Attorney, Agent or Firm:
BEIJING YUEHE INTELLECTUAL PROPERTY AGENCY CO., LTD (CN)
Download PDF: